top of page
Question mark

KRAS is the most common biomarker associated with lung, colorectal, pancreatic plus other cancers. Identified 50 years ago, researchers have learned that different sub-types of KRAS respond to treatments differently.  

​

We founded KRAS Kickers to actively monitor and share KRAS-related research developments, information and clinical trials within the community that will benefit the most, us.  We are the patients that need the best outcomes to live our lives.  

A biomarker is something measured by your doctor.  This helps to identify the best treatment options for your cancer.  KRAS targeted therapies are becoming options. 

More Videos @KRASKickers on YouTube

Frequently asked questions
Fom
Woman looking through microscope

What is 

KRAS?

Genentech_Logo.png_dark blue text that reads, "Genetech." Gray italicized text that reads, "a member of the Roche Group."
Blue capitalized text on a gray background. Text reads, "Amgen."
Dark blue text on top of sea foam text. Text reads, "Verastem Oncology."
Black capitalized text that reads, "Revolution Medicine."
bottom of page